VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog
โ† Value Add PulseFUNDING$18B vs $61B

Europe's Defense-Tech Rounds Are Catching Up to the US

Helsing's $1.8 billion round at an $18 billion valuation puts a concrete number on how fast European defense-tech financing is closing the gap with a US market that produced four separate billion-dollar-plus rounds this year alone.

$18B
Helsing valuation
$61B
Anduril valuation
$14.6B (5 months)
US defense funding YTD
$9.6B
2025 full-year record
TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
July 14, 2026
2 min read
ShareXLinkedInEmail
THE RUNDOWN
1

Helsing's $1.8 billion Series E at an $18 billion valuation is Europe's biggest-ever defense-tech round, arriving in the same year the US produced four separate billion-dollar-plus defense-tech financings

2

US comparables: Anduril's $5 billion Series H at a $61 billion valuation (Thrive Capital, Andreessen Horowitz), Shield AI's $2 billion Series G (Advent International, JPMorgan), Saronic's $1.75 billion Series D (Kleiner Perkins), and Mach Industries' $300 million Series C at a $1.8 billion valuation

3

US defense-tech funding hit $14.6 billion in just the first five months of 2026, already above the prior full-year record of $9.6 billion set in all of 2025

4

The valuation gap remains wide -- Helsing's $18 billion is less than a third of Anduril's $61 billion -- but the fact that Europe can now produce a round measured on the same order of magnitude at all marks a real shift from a category that barely existed at scale two years ago

TC
The VC Read ยท Trace's TakeTrace Cohen

Helsing at $18 billion sitting in the same sentence as Anduril at $61 billion is the real headline here, not the dollar figure itself -- two years ago there was no European defense-tech company you could even put in that sentence. The gap is still wide, but oversubscription on a round this size tells me the investors closest to the deal think it closes faster than the current multiple implies.

Put Helsing's $1.8 billion Series E next to this year's US defense-tech mega-rounds and the comparison writes itself. Anduril Industries raised a $5 billion Series H in May at a $61 billion valuation, led by Thrive Capital and Andreessen Horowitz. Shield AI closed a $2 billion Series G in March led by Advent International and JPMorgan Chase. Saronic secured a $1.75 billion Series D led by Kleiner Perkins. Mach Industries, founded by a then-19-year-old MIT dropout, closed a $300 million Series C in June at a $1.8 billion valuation. Four separate US rounds, each individually larger in absolute dollar terms than what most European defense-tech companies could have raised in total two years ago -- and Helsing's $18 billion valuation, while still less than a third of Anduril's, is now large enough to appear on the same chart without an asterisk.

The US defense-tech pace explains the scale of the gap Helsing is closing: American defense-tech funding hit $14.6 billion in just the first five months of 2026 alone, already surpassing the prior full-year record of $9.6 billion set across all of 2025. That's the market Helsing's round is now being measured against, and the fact that a single European round can be discussed in the same sentence as Anduril's Series H -- even at roughly a third of the valuation -- is itself the story.

What's different about Helsing's path to this scale is its customer base: unlike Anduril, Shield AI and Saronic, which sell primarily to the US Department of Defense and allied governments through US-centric procurement relationships, Helsing is built around European and NATO-adjacent government customers, a genuinely separate market that had lacked a well-capitalized, venture-backed champion of its own until relatively recently.

For US defense-tech investors, Helsing's raise is a signal that the category's capital intensity and valuation growth aren't uniquely American phenomena -- global defense-AI demand is scaling across multiple procurement relationships simultaneously, which both validates the broader thesis and expands the competitive set any single portfolio company eventually has to reckon with internationally. For European LPs, it's proof that a defense-tech company built primarily around European government customers can now attract the same caliber of growth-equity and sovereign-adjacent investors -- Goldman Sachs Alternatives, CPPIB -- that have backed the largest US rounds.

The bear case: valuation convergence between Helsing and its US peers assumes European defense budgets and procurement cycles scale at a similar pace to the US, an assumption that hasn't been tested at this capital intensity in Europe before. What to watch next: whether Helsing's next round, if it comes within the next 12-18 months, meaningfully narrows the valuation gap with Anduril further, and whether other European defense-tech startups follow with their own billion-dollar-plus rounds.

ShareXLinkedInEmail

Originally reported by Value Add Pulse. Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse

THE WIRE in your inboxโ€” Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

FUNDING$1.8B at $18B

Helsing Raises $1.8B, Europe's Biggest Defense Round

Munich-based Helsing closed a $1.8 billion Series E at an $18 billion valuation, Europe's biggest-ever defense-tech round, with Goldman Sachs Alternatives, CPPIB and JPMorgan joining as new investors amid oversubscribed demand.

FUNDING$125M Series C

Gauntlet Raises $125M Series C From SBI Holdings

DeFi risk-management firm Gauntlet raised $125 million in a Series C with Japan's SBI Holdings as the sole investor, its largest raise ever, to expand into stablecoins, tokenization and traditional capital-markets infrastructure.

FUNDING$55M Series D

Drug Farm Raises $55M Series D for Rare Disease Drug

Biotech Drug Farm raised a $55 million Series D to advance DF-003, a Phase 3 ALPK1 inhibitor for rare autoinflammatory disorder ROSAH syndrome, alongside DF-006, a Phase 2 immunomodulator for hepatitis B and liver cancer.

@Trace_Cohenยทt@nyvp.com